Use access key #2 to skip to page content.
$7.68 -0.14 (-1.79%)
7/18/2008 4:00 PM

Halozyme Therapeutics, Inc. (HALO)

CAPS Rating:
**

A biopharmaceutical company dedicated to the development and commercialization of recombinant human enzymes for the drug delivery, palliative care, oncology and infertility markets.

View All Commentary (HALO)

Recs

0

Avatar jmofield (< 20) Submitted: 5/13/08 6:31 PM : Underperform Start Price: $5.30 HALO Score: 5.19

I have decided for the next serveral weeks to change my investment strategy to be short stocks trading between $1.50 and below $10 with a market cap of more than $100 million. My goal is to acheive at least a 60% sucess rate of beating the S&P Index. I am looking for 30% of my picks beating the S&P Index by more than 5% with an average per pick of at least 1.50. I am only looking to hold these positions for approximately 10-15 days.

All the picks that I select are from screening criteria that I have developed using software from Vectorvest. I find it to be a good screening tool. For game playing purposes, since I always try to have 200 picks going at once, it's a shot gun approach with only short term trading in mind.

Report this Post Replies: 0 | Reply

Featured Broker Partners